| Molecular Weight: | 465.58 |
| Formula: | C31H31NO3 |
| Purity: | ≥98% |
| CAS#: | n/a |
| Solubility: | DMSO up to 50 mM |
| Chemical Name: | (3-((4-(tert-butoxy)phenoxy)methyl)-3,4-dihydroisoquinolin-2(1H)-yl)(naphthalen-1-yl)methanone |
| Storage: | Powder:4oC 1 year. DMSO:4oC3 month;-20oC 1 year. |
Biological Activity:SR10067 is a potent and specific synthetic REV-ERB agonist that binds to REV-ERB-α with an EC50 ~170 nM and REV-ERB-β with EC50 ~160 nM. Potency of SR10067 was also considerably better in a cotransfection assay using full-length REV-ERBa along with the BMAL1 promoter luciferase reporter (EC50 ~140 nM). It also has good in vivo plasma/brain exposure. Comparing to SR9011 and SR9009, SR10067 has 4-5 folds improvement in potency both in vitro and in vivo. IP administration of SR10067 regulates sleep architecture and emotional behaviour in mice. It induces wakefulness and reduces REM and slow-wave sleep. It can also reduce anxiety-like behaviour. These results indicate that pharmacological targeting of REV-ERB may lead to the development of novel therapeutics to treat sleep disorders and anxiety.How to Use: In vitro: SR10067 was used at 5-10 µM concentration in vitro and in cellular assays.In vivo: IP administration of SR10067 was used at 30 mg/kg to mice. Reference:
- 1.Banerjee S, et al. Pharmacological targeting of the mammalian clock regulates sleep architecture and emotional behaviour. (2014) Nat Commun. 5:5759.
SR10067_spec.pdf
SR10067_MSDS.pdfProducts are for research use only. Not for human use.ebiomall.com
>
>
>
>
>
>
>
>
>
>
>
>
根据组成不同,可分为两种,弱酸及其对应的强碱弱酸盐,弱碱及其对应的强酸弱碱盐。
因为HF可以和NaOH反应生成NaF和水,当NaOH反应完之后,NaF就可以与HF组成缓冲溶液,所以说可以直接使用NaOH和HF来配制缓冲溶液。
这也是一般配制缓冲溶液的方法,也就是用强碱和弱酸(或者强酸和弱碱)来配制缓冲溶液。
百度教育团队【海纳百川团】为您解答。
感谢您的采纳 O(∩_∩)O 。如有疑问,欢迎追问。
酶提取技术,属地球化学勘查学科。其是由克拉克(J.R.Clark)等人于20世纪80年代末和90年代初研制出的一种利用葡萄糖氧化酶提取矿物颗粒表面的非晶质锰的氧化膜寻找隐伏矿的方法。1995年以后已广泛应用。
因为常用的缓冲溶液由弱酸及其共轭酸盐组合而成,当加入酸时,弱酸盐部分转化为弱酸;当加入碱时,弱酸部分转化为弱酸盐。而弱酸在水中不完全电离,弱酸盐在水中可以水解,所以ph变化较小,保持了溶液的PH基本不变。

